Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats.
The hepatic synthesis of several proteins, including both albumin and transferrin is increased in the nephrotic syndrome. While active suppression of albumin synthesis by lymphokines has been described, it has been assumed that augmentation of albumin synthesis is governed by a physical factor, plasma oncotic pressure (pi), and that this regulation is by a direct effect of pi on hepatocytes. The mechanisms have not been defined. Furthermore, experiments relying on suppression of protein synthesis may only test non-specific inhibitory effects of the experimental intervention. We tested an alternative hypothesis that a serum factor(s) present in hypooncotic states stimulates albumin synthesis. We incubated an immortalized cell line derived from rat hepatocytes (H4 cells) with serum from Nagase analbuminemic rats (NAR) and rats with passive Heymann nephritis (HN), a model of the nephrotic syndrome. Synthesis (incorporation of [35S]methionine) into both albumin and transferrin was increased significantly. The stimulatory effect of these sera was not extinguished by addition of rat or human albumin to the medium prior to or during incubation, even when pi in the incubation medium was increased to normal plasma levels by added albumin. Incorporation of [35S]methionine into albumin was 7841 +/- 394 cpm/mg cell protein using 10% NAR serum in the presence of human albumin (medium pi 26.1 +/- 0.17) versus 5149 +/- 420 cpm incorporation (P < 0.05) in the presence of control serum and in the absence of added albumin (medium pi 2.06 +/- 0.26 mm Hg, P < 0.001). The stimulatory activity was preserved following heating of serum for one hour at 60 degrees C.(ABSTRACT TRUNCATED AT 250 WORDS)
Sun
X
X
Department of Medicine, University of California Davis School of Medicine.
Kaysen
G A
GA
D000818:Animals; D001685:Biological Factors / Q000494:pharmacology; D001798:Blood Proteins / Q000494:pharmacology; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis; D005921:Glomerulonephritis / Q000097:blood; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008297:Male; D009404:Nephrotic Syndrome / Q000097:blood*; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D011922:Rats, Mutant Strains; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000096:biosynthesis* / Q000172:deficiency*; D014168:Transferrin / Q000096:biosynthesis*
D001685:Biological Factors; D001798:Blood Proteins; D012709:Serum Albumin; D014168:Transferrin; D012313:RNA; D004247:DNA